Stroke in autoimmune rheumatic diseases.

Rheumatol Int · 2026 · PMC13050762 · PMID 41936645

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Biologic DMARDs did not significantly modify stroke risk, while targeted synthetic DMARDs showed a nonsignificant trend toward reduction [ 35 ].

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.